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Health status measured by the Clinical COPD
Questionnaire (CCQ) improves following post-acute
pulmonary rehabilitation in patients with advanced
COPD: a prospective observational study
Eléonore F van Dam van Isselt1,2, Monica Spruit1, Karin H Groenewegen-Sipkema3, Niels H Chavannes1 and Wilco P Achterberg1
AIMS: To evaluate outcomes of the Clinical Chronic obstructive pulmonary disease (COPD) Questionnaire (CCQ) in patients with
advanced COPD admitted for a post-acute pulmonary rehabilitation (PR) programme and to relate (change in) health status to lung
function, degree of dyspnoea and (change in) functional capacity.
METHODS: This is a prospective observational study in patients with advanced COPD admitted for a post-acute PR programme in a
skilled nursing facility. Health status (CCQ) and functional capacity were measured before and after rehabilitation.
RESULTS: Health status measured by the CCQ was severely impaired and showed significant and clinically relevant improvement
during the post-acute PR programme. Moderate to strong correlations were found between CCQ scores and functional capacity on
admission and at discharge. Moderate correlations were found between improvement in CCQ scores and improvement in
functional capacity. No correlation was found between CCQ scores and lung function (forced expiratory volume in 1 s % predicted).
CONCLUSIONS: Health status measured by the CCQ improves following a post-acute PR programme in patients with advanced
COPD and correlates with improvement in functional capacity. These results suggest that the CCQ is sensitive to change in response
to PR in this specific group of patients.
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INTRODUCTION
In chronic obstructive pulmonary disease (COPD), health-related
quality of life (HRQoL) is increasingly recognised as an important
measurement that reflects the patient’s perspective of the impact of
the disease on symptom burden, functional capacity and psycho-
social functioning.1,2 Therefore, more traditional parameters of
disease severity (such as lung function) should be supplemented
with measurements of HRQoL or health status. However, instru-
ments to assess HRQoL or health status are often time-consuming
and/or relatively difficult for the patients to comprehend. Further-
more, although instruments to measure HRQoL are widely used as
important outcome measurements in research, their use in daily
practice (especially in primary care) is limited.
In 2003 van der Molen et al.3 developed and validated the
Clinical COPD Questionnaire (CCQ). The CCQ is a simple and
reliable 10-item tool that focuses not only on the clinical status of
the airways, but also on functional limitations and psychosocial
dysfunction. The CCQ consists of three separate domains (i.e.,
symptoms, functional state and mental state) and was originally
developed to measure the clinical health status in patients with
COPD. Treatment in clinical practice can be aimed at these
subdomains, which elaborates on tailor-made medicine in patients
with COPD. The CCQ can also be used to evaluate the adequacy of
clinical management4 and to assess functional performance.5 In
fact, the functional state domain of the CCQ is reported to be the
best patient-reported outcome tool for assessing functional
performance in patients with COPD in primary care.6 Furthermore,
the CCQ can be used to measure the effect of integrated disease
management interventions in primary care6 and to predict
exacerbations7 and mortality2 in patients with mild to moderate
COPD. However, little is known about the use of the CCQ in
patients with advanced COPD, or its use as a primary outcome
measure in pulmonary rehabilitation (PR).
Therefore, the aim of the present study was to evaluate
outcomes of the CCQ in patients with advanced COPD admitted
for post-acute PR and to correlate (improvement in) health status
measured by the CCQ to lung function, degree of dyspnoea and
(improvement in) functional capacity.
MATERIALS AND METHODS
Design and setting
This is a prospective observational study designed to evaluate outcomes of
the CCQ in patients with advanced COPD and to relate (improvement in)
health status to lung function, degree of dyspnoea and (improvement in)
functional capacity. The study was conducted at a skilled nursing facility
(SNF) that offers geriatric rehabilitation for patients with advanced COPD.
Data were collected from the patients’ files by the patients’ physicians and
transferred to an anonymous data file (SPPS 20). Given the fact that this
observational study measured a form of structured usual care, no written
informed consent was required.
Baseline measurements (T0) were collected and performed within 3 days
after admission to the SNF; these consisted of patient and disease
characteristics, health status (CCQ), degree of dyspnoea (modified Medical
Research Council (mMRC) scale) and functional capacity (Barthel Index (BI)
and the Six-Minute Walking Test (6MWT)). At discharge from the SNF (T1),
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health status and functional capacity were measured again. Data were
collected from May 2009 until January 2011.
Participants
Patients with severe (Global Initiative for Chronic Obstructive Lung Disease
(GOLD)8 stage 3) to very severe (GOLD stage 4) COPD, admitted to the
hospital for an acute exacerbation, were indicated for the PR programme by
a pulmonologist. PR was considered appropriate when patients suffered
from high symptom burden and/or a substantial decline in health status and
functional capacity without sufficient recovery during hospital stay.
Furthermore, a multidisciplinary approach was required to achieve improve-
ment in health status instead of physical therapy alone. Patients who lacked
motivation or patients with prominent psychiatric or cognitive dysfunction
interfering with PR were excluded from the programme. All patients
admitted to the PR programme were eligible to participate in this study.
Pulmonary rehabilitation programme
The PR programme was offered at an SNF that offers geriatric rehabilitation.
Geriatric rehabilitation consists of post-acute restorative inpatient treatment
with a multidisciplinary patient-centred approach in a therapeutic
environment.9 Geriatric rehabilitation does not differ from rehabilitation
medicine in its approach. However, patients admitted to geriatric rehabilita-
tion programmes do have different characteristics: higher age, substantial co-
morbidity and limited functional and training capacity.10 The SNF at which
the present study was conducted has one ward with a multidisciplinary team
that is specialised in post-acute care and rehabilitation for patients with
advanced COPD.11 The PR programme contains several modules on different
aspects of rehabilitation. Goal setting and duration of the programme is
tailored to the individual patient, and the programme is evaluated weekly
and adjusted (as needed) by the multidisciplinary team. All patients follow a
standardised weekly programme that contains a minimum of five 40-min
physiotherapy sessions, occupational therapy once or twice a week, analysis
and evaluation of nutritional status every week and weekly group sessions
(education of patients and relatives, and peer support contact). Assignment
to therapies is stringent. A detailed description of the PR programme was
recently published.11
Health status and degree of dyspnoea
Health status was measured using the Dutch version of the CCQ.3 The CCQ
is a validated and reliable 10-item, self-administered questionnaire. The
CCQ consists of three subdomains: symptoms, functional state and mental
state. Items are scored on a Likert scale (range 0–60). The final score is the
sum of all items divided by 10; separate scores for all three domains can be
calculated. Higher scores indicate a worse health status. The minimal
clinically important difference (MCID) of the CCQ total score is − 0.4.12
Degree of dyspnoea was measured using the mMRC dyspnoea scale.7 The
mMRC is an ordinal four-point scale (grades 0–4) based on degrees of
various physical activities that precipitate dyspnoea. Grade 4 represents
the most severe category.
Functional capacity
Functional capacity was measured by the modified BI and the 6MWT. The
BI measures activities of daily living and is a valid, reliable and widely used
instrument to assess activities of daily living improvement during
rehabilitation programmes.13 The total score ranges from 0 to 20, with
20 representing complete functional independence. The MCID for the BI is
not well established for COPD patients. In stroke patients the MCID of the
BI was calculated at +1.85.14 The BI was assessed by a specialised nurse of
the SNF.
The 6MWT is a practical, easy-to-perform and widely used instrument for
measuring exercise capacity in patients with COPD. The 6MWT is strongly
predictive of survival in patients with COPD and an important outcome
measure for PR.15,16 The MCID for the 6MWT in patients with severe COPD
is +26 (±2) m.17 The 6MWT was assessed by a physiotherapist of the
multidisciplinary team of the SNF in a standardised setting in accordance
with international guidelines.15
Statistical analysis
All data were processed using SPSS (IBM SPSS Statistics for Windows,
Version 20.0, IBM, Armonk, NY, USA). Descriptive analyses were used for
measurements on admission (T0) and at discharge (T1). To compare the
mean outcome measurements on admission (T0) and discharge (T1), the
paired sample t-test was used. In case of skewed data (BI), the non-
parametric Wilcoxon test was used. To investigate potential regression to
the mean, a linear regression analysis was performed for change (T1− T0)
against baseline measurements (T0). Pearson’s correlation coefficient was
calculated to determine the strength of linear correlations between pairs of
variables of interest. In case of skewed data or measurements at interval
level, Spearman’s correlation coefficient was calculated. We defined
statistical significance at P≤ 0.05 (two-sided level of significance).
RESULTS
Study population
A total of 63 patients entered the programme during the specified
period and were eligible to participate in this study. Of them, two
were excluded because of a different diagnosis (one for asthma
and one for small airway disease), two (5%) died during the
rehabilitation programme and one dropped out because of lack of
motivation.
Patient and disease characteristics are presented in Table 1.
Mean length of admission to the SNF was 44.1 (±30.2) days. The
study population consisted of 30 women and 31 men with a
mean age of 68.9 (±9.9) years. All patients had advanced COPD
(GOLD stage 3 or 4) with a mean forced expiratory volume in 1 s
(FEV1)% predicted of 31.6 (±10.8); in addition, 17 patients (28%)
were on long-term oxygen therapy.
Health status, degree of dyspnoea and functional capacity on
admission
On admission, the mean CCQ score was 3.5 (±0.9), indicating
severely limited health status, and the mean score on the mMRC was
3.8 (±1.1). Functional capacity was limited, as the median BI score
(17 (interquartile range 15–18)) indicated care dependency and
the mean 6MWT (208 (±119)m) indicated limited exercise capacity.
Course of health status and functional capacity during the PR
programme
During the PR programme there was a significant and clinically
relevant improvement in health status (CCQ) and functional
capacity (BI and 6MWT) (Table 2). On admission the mean CCQ
was 3.5 (±0.9, range 1.3–5.8) and was 2.2 (±1.0, range 0.6–4.4) at
discharge. All three subdomains of the CCQ showed significant
improvement: of all patients, 86.8% showed an improvement on
the CCQ equal to the MCID or more; in two patients the CCQ score
Table 1. Patient and disease characteristics on admission
(baseline/T0)
No. of patients 61
Age in years (s.d.) 68.9 (9.9)
Sex: woman, n (%) 30 (49)
Living alone, n (%) 28 (46)
LOA-H in days (IQR) 8 (7–11)
LOA-SNF in days (IQR) 35 (21–61)
GOLD 3, n (%) 29 (48)
GOLD 4, n (%) 32 (52)
FEV1% of predicted (s.d.) 32.9 (10.8)
LTOT, n (%) 17 (28)
Smoker, n (%) 10 (16.5)
Categorical variables are described as frequencies, while continuous
variables were tested for normality and are presented as mean (s.d.) or
median (IQR) in case of skewed data.
Abbreviations: FEV1, forced expiratory volume in 1 s; GOLD, Global
Initiative for Chronic Obstructive Lung Disease; IQR, interquartile range
LOA-H, length of admission during hospital stay; LOA-SNF, length of
admission during rehabilitation; LTOT, long-term oxygen therapy.
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did not change; and in three patients the score increased,
indicating a deterioration of health status during the programme.
On admission the median BI score was 17 (range 5–20) and was 20
(range 11–20) at discharge. In 41 patients the BI improved two
points or more, in 2 patients the BI at discharge was lower than on
admission and in 9 patients the BI did not change during the
programme. However, all these latter patients had a maximum
score (19 or 20) on admission. The mean 6MWT improved from
208m (range 36–568m) on admission to 274 m (range 61–634m)
at discharge. In 71.7% of the patients the 6MWT improved >26m.
In two patients the 6MWT did not change and in six patients the
6MWT decreased.
To investigate potential for regression to the mean, a linear
regression analysis was performed for change (T1− T0) against
baseline measurements (T0). Figure 1 shows the relation between
improvement in CCQ (CCQ-delta) and CCQ at baseline (CCQ-T0).
Results from the linear regression model show a Y-intercept (b0) of
0.36 and a gradient of the regression line (b1), representing the
change in outcome variable (CCQ-delta) associated with one-unit
change in the predictor (CCQ-T0) of − 0.473.
Relationship between health status, lung function, functional
capacity and degree of dyspnoea on admission and discharge
To determine the correlation between health status as measured
by the CCQ and lung function (FEV1%pred), functional capacity
(6MWT and BI) and degree of dyspnoea (mMRC) on admission and
at discharge, we calculated the correlation coefficients between
these variables (Table 3). On admission, there was a moderate to
strong correlation between CCQ (CCQ total score and CCQ
function domain score) and functional capacity measured by the
6MWT (CCQ total score: r=− 0.400, P= 0.002, CCQ function score:
− 0.431, P= 0.001) and the BI (CCQ total score: r=− 0.481,
Po0.001, CCQ function score: − 0.573, Po0.001). No correlation
was found between the CCQ on admission (CCQ total score and
CCQ separate domain scores) and lung function measured by the
FEV1% of predicted. On admission, there was a moderate
correlation between the mMRC dyspnoea scale and the CCQ total
score and the CCQ function domain score. We found no significant
correlation between the mMRC dyspnoea scale and the symptom
domain of the CCQ. At discharge, we found a strong correlation
between the CCQ total score and the CCQ function domain score
and functional capacity measured by the 6MWT (CCQ total score:
r=− 0.572, Po0.001) and the BI (CCQ total score: r=− 0.539,
Po0.001). To determine whether patients with an improvement
in CCQ of more than the MCID are the same as those with clinically
relevant functional improvements, we calculated the correlation
coefficient between these variables. There was a moderate
correlation between improvement in health status (CCQ-total
score) and improvement in functional capacity (6MWT): r=− 0.432,
P= 0.002. We found no significant correlation between improve-
ment in CCQ and improvement in BI or between improvement in
6MWT and improvement in BI. Of the subjects with an
improvement in the CCQ score equal to or greater than the
MCID, 67.7 and 73.9% also showed a clinically relevant improve-
ment on the 6MWT and the BI, respectively. Overall, 45.3% of the
subjects showed clinically relevant improvements on all three
outcome measurements (CCQ, 6MWT and BI). We found no
correlation between baseline lung function (FEV1% of predicted)
and improvement in health status or functional capacity.
DISCUSSION
Main findings
The first main finding of this study is that health status measured
by the CCQ is severely impaired in this group of patients. Second,
health status measured by the CCQ showed substantial and
clinically relevant improvement during the PR programme; this
improvement correlates well with improvement in functional
capacity, indicating that the CCQ is sensitive to change in
response to PR.
Strengths and limitations of this study
This is the first study that describes the course of health status as
measured by the CCQ in patients with advanced COPD during a
post-acute PR programme, with follow-up of almost all patients
and few missing data at follow-up. However, this study warrants
some limitations. Our population might be biased because we did
not collect information on patients who were selected for the PR
programme but were not motivated to participate. Patients who
refused to participate were discharged from the hospital. The
health status and functional capacity of our population may be
even worse than that of the initial population that was indicated
for PR in the hospital, because most patients who refused to
participate were discharged home.
Furthermore, part of the improvement in health status measured
by the CCQ might be caused by the ‘in care effect’ of patients
participating in a study. PR is expected to improve functional
Table 2. Outcomes of measurements on admission (T0) and
discharge (T1)
T0 T1 P
CCQ (s.d.) 60 3.5 (0.9) 53 2.2 (1.0) o0.001a
Symptoms 60 3.7 (1.1) 54 2.4 (1.1) o0.001a
Functional state 60 3.9 (1.2) 53 2.6 (1.4) o0.001a
Mental state 60 2.3 (1.6) 53 1.3 (1.4) o0.001a
Barthel Index (IQR) 61 17 (15–18) 58 20 (17–20) o0.001b
6MWT, metres (s.d.) 58 208 (119) 54 274 (122) o0.001a
Variables were tested for normality and are presented as mean (s.d.) or
median (IQR) in case of skewed data.
Abbreviations: 6MWT, Six-Minute Walking Test; IQR, interquartile range.
aVariables were compared between T0 and T1 using a paired sample t-test,
as appropriate.
bVariables were compared between T0 and T1 using a paired sample
















Figure 1. Scatterplot showing the relation between improvement
in CCQ (CCQ-delta) and CCQ at baseline (CCQ-T0). Y-intercept
(B0)= 0.36°; gradient of regression line (b1) representing the change
in outcome variable (CCQ-delta) associated with one-unit change in
the predictor (CCQ-T0)=− 0.473.
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capacity, whereas improvement in the CCQ might partly be caused
by participation in a study like the present one. Correlation
between these two outcome measurements might therefore be
overestimated. However, because of the observational design of
the study and the fact that we solely measured a form of
structured usual care, the ‘in care effect’ cannot be ruled out
completely, but probably has limited influence on our results.
As the current study is an analysis of change between baseline
and follow-up, a regression to the mean effect should be
considered as a possible cause of observed change. The results
of the linear regression analysis show that, when adjusted for
baseline, improvement in CCQ reduces from − 1.3 to − 0.5. This
means that even after adjusting for regression to the mean there
continues to be a significant and clinically relevant change.
To evaluate the use of the CCQ in this group of patients,
comparison of the CCQ with another HRQoL instrument that is
regularly used in this group of patients, namely, the Chronic
Respiratory Questionnaire Self-Administered Standardized Format
(CRQ-SAS),18 was initially included in the design of the study.
However, during our study, compliance with the CRQ-SAS was
very low, leading to very high rates of missing data (⩾50%), and
we were therefore unable to present reliable results from the CRQ-
SAS. Nevertheless, this is still an interesting result, as it also
confirms that HRQoL instruments such as the CRQ are often time-
consuming and relatively difficult for patients to comprehend,
leading to limited use, and usefulness, in daily practice.
Compliance with the CCQ was, however, very good, leading to
very few missing data (o2% at baseline; 8% at follow-up).
The last limitation is the fact that we did not have a control
group, and although our results suggest that the CCQ is a
responsive instrument for measuring change in health status
following a post-acute PR programme in patients with advanced
COPD, a randomised controlled trial would serve well to further
confirm these findings.
Interpretation of findings in relation to previously published work
Literature on health status as measured by the CCQ in patients
with advanced COPD is scarce. The CCQ was originally developed
and validated by van der Molen et al.3 and has since been
validated for the Italian19 and Greek language20 in patients with
stable COPD. Compared with our results, data from these latter
studies show lower CCQ scores (total scores and separate domain
scores). This can be explained by the fact that our population
suffered from a recent exacerbation and that exacerbations have a
negative effect on health status. Recently, Kocks et al.21 reported
data from two randomised controlled COPD exacerbation trials on
the day-to-day course of patient-reported health status (as
measured with the CCQ) during exacerbations. They reported
results from 210 COPD patients admitted to hospital for an acute
exacerbation (mean age 70.6 years, mean FEV1: 37% of predicted);
the CCQ total score on admission to the hospital was 3.3 (±0.93).
Although this score is similar to our results, the time at which the
CCQ score was measured is different, as we measured the CCQ on
admission to the SNF. In the study by Kocks et al.,21 the CCQ total
score improved rapidly during hospital stay, with a mean score of
2.3 on day 7. These results seem to confirm that our population
indeed consisted of those patients who failed to recover during
hospital stay.
Our results show a substantial and clinically relevant improve-
ment in health status during the PR programme. This suggests that
the CCQ is sensitive to change in response to PR in this group of
patients. Literature on the responsiveness of the CCQ to
interventions such as PR, or other forms of integrated care, is also
scarce. The Picasso Bocholtz study6 evaluated the effect of
Integrated Disease Management on health status as measured
by the CCQ in 106 primary-care patients with mild to moderate
COPD (mean age 64 years, mean FEV1 63% of predicted). At the
start of the study, the mean CCQ total score was 1.5, with an overall
improvement of − 0.4 (P= 0.001) during follow-up. In the study by
Damato et al.,19 the CCQ showed sensitiveness to change in 46
patients undergoing an inpatient PR programme; the CCQ total
score improved from 2.0 at baseline to 1.3 after PR (Po0.001). Our
data are in line with these studies, indicating that the CCQ is
sensitive to change following interventions such as PR.
We found no correlation between CCQ total score at baseline
and lung function (FEV1% of predicted). This is in line with a
growing body of evidence showing that traditional measurements
of disease severity (such as lung function) do not correlate well
with HRQoL or health status.1,2 However, our results differ from
Table 3. Correlations of CCQ score (total and subdomains) on admission
(T0), discharge (T1) and change in CCQ scores (T1−T0) with measure-
ments of functional capacity, degree of dyspnoea and lung function




r − 0.481c − 0.400c 0.392c − 0.126
P o0.001 0.002 0.003 0.343
N 60 57 55 59
CCQ-symptoms
r − 0.209 − 0.167 0.117 − 0.072
P 0.126 0.235 0.414 0.605
N 55 52 51 54
CCQ-function
r − 0.573c − 0.431c 0.437c − 0.183
P o0.001 0.001 0.001 0.186
N 55 52 52 54
CCQ-mental
r − 0.192 − 0.239 0.183 − 0.113
P 0.156 0.084 0.193 0.410
N 56 53 52 55
T1
CCQ-total

















r − 0.099 − 0.432c 0.058 -0.223
P 0.481 0.002 0.694 0.113
N 53 50 48 52
CCQ-symptoms
r − 0.110 − 0.449c 0.062 -0.151
P 0.468 0.002 0.696 0.321
N 46 44 42 45
CCQ-function
r − 0.201 − 0.313d 0.051 − 0.304d
P 0.186 0.041 0.748 0.045
N 45 43 42 44
CCQ-mental
r − 0.067 − 0.268 0.007 − 0.069
P 0.568 0.78 0.963 0.650
N 46 44 42 45
Abbreviations: 6MWT, Six-Minute Walking Test; BI, Barthel Index; FEV1,
forced expiratory volume in 1 s; mMRC, modified Medical Research Council.
aSpearman’s correlation coefficient was calculated for non-normally
distributed (BI) and interval (mMRC) measurements.
bPearson’s correlation coefficient was calculated for normally distributed
measurements (6MWT, FEV1%pred).
cCorrelation is significant at the 0.01 level (two-tailed).
dCorrelation is significant at the 0.05 level (two-tailed).
Outcomes of CCQ in patients with advanced COPD
EF van Dam van Isselt et al
4
npj Primary Care Respiratory Medicine (2014) 14007 © 2014 Primary Care Respiratory Society UK/Macmillan Publishers Limited
those of van der Molen et al.3 and Damato et al.19 In both latter
studies a significant correlation was found between the mean
FEV1% of predicted and the mean CCQ total score (van der Molen
et al.: r=− 0.38, Po0.01; Damato et al.: r=− 0.57, Po0.01). These
correlation coefficients account for the total groups, including
healthy smokers and subjects at risk. In COPD patients (GOLD
stage 1–4), van der Molen et al. reported a correlation of r =− 0.49
(Po0.001). An explanation for these conflicting results can be that
all our patients suffered from advanced COPD and thus differed
substantially from those in the other two studies. With disease
progression, health status deteriorates and is probably relatively
less influenced by the degree of airflow limitation. During the PR
programme, we found no correlation between baseline lung
function (FEV1% of predicted) and improvement in health status
or functional capacity. This suggests that disease severity, as
measured by the degree of airflow limitation, does not seem to
predict which patients benefit most from the PR programme.
Implications for future research, policy and practice
In the present study, we evaluated the use of the CCQ in patients
with advanced COPD admitted for post-acute PR. Considering our
results, we recommend that the CCQ be used as a (primary)
outcome measure in an experimental study design to evaluate the
effect of post-acute (inpatient/outpatient) PR on health status in
patients with advanced COPD. Our study also confirms that the CCQ
is a practical and easy-to-use instrument for assessing health status,
not only in research but also in daily practice. Our study was
conducted with patients who were recruited after hospital admis-
sion for an acute exacerbation and admitted for inpatient PR. Thus,
our patients were not treated in primary care during this study.
However, in primary care, patients with advanced COPD are a
growing group, with a huge burden of disease and in great need of
better care. Therefore, research should also focus on the course of
health status measured by the CCQ in patients with advanced COPD
in primary care and the clinical use of the CCQ in elaborating tailor-
made medicine for this specific group of patients.
Conclusions
In patients with advanced COPD, health status measured by the
CCQ improves after a post-acute PR programme. Moderate-to-
strong correlations were found between the CCQ scores and
functional capacity, showing that the CCQ correlates well with
other important outcome measurements of PR. These results
suggest that the CCQ is sensitive to change in response to PR in
this group of patients.
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